Medications

Bempedoic acid improves outcomes in statin-intolerant patients

The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholesterol who were unable to tolerate ...

Cardiology

Long-term outcomes of PCI, CABG compared for multivessel CAD

For patients with multivessel coronary artery disease, the rates of major adverse cardiac events and safety events do not differ for those receiving percutaneous coronary intervention (PCI) with everolimus-eluting stent or ...

Cardiology

Results from the FORECAST trial reported

In the FORECAST randomized clinical trial, the use of fractional flow reserve management derived from computed tomography (FFRCT) did not significantly reduce costs but did reduce the use of invasive coronary angiography ...

Cardiology

Study looks at changes in outcomes for coronary revascularization

The most common type of heart disease—coronary artery disease—affects 6.7% of adults and accounts for 20% of 2 in 10 deaths of adults under age 65. The condition builds over time as inflammation and cholesterol-containing ...

page 1 from 8